Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 83634-400

2 FDA label images from Avenacy, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 83634-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Biv08 0002 01)

Figure 1 (Biv08 0002 01)
Chemical structure diagram of bivalirudin, the active ingredient in the injection powder lyophilized for solution. The structure includes detailed peptide linkages and specific side chains as part of the molecular representation.*
FDA Label Image

Figure (Biv08 0002 02)

Figure (Biv08 0002 02)
Label for Bivalirudin for Injection 250 mg per vial, lyophilized powder for intravenous use. The single-dose vial label states to discard unused portion. Manufactured by Avenacy, LLC, it includes storage instructions between 20 to 25°C with permitted excursions. The label also displays an NDC barcode and space for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.